GLP-1 and multi-agonists
PRN tracks this theme because it connects reader demand with published research, regulatory questions and clinical relevance.
GLP-1 receptor agonist use in patients with minor stroke is associated with lower risk of post-stroke dementia
Journal of neurology · 2026 Nov 7
PubMedGLP-1 receptor agonists as potential disease-modifying agents in Parkinson's and Alzheimer's disease: mechanisms, clinical trial evidence, and the neuroprotection horizon
Frontiers in aging neuroscience · 2026
PubMedThe impact of GLP-1 receptor agonists on chemotherapeutic efficacy: insights from GWAS and experiments
Frontiers in pharmacology · 2026
Peptide therapeutics
PRN tracks this theme because it connects reader demand with published research, regulatory questions and clinical relevance.
Eight-week omega-3 polyunsaturated fatty acid supplementation alters but does not attenuate exercise-induced muscle damage in older adults: a randomised controlled trial
Age and ageing · 2026 Oct 31
PubMedGLP-1 receptor agonists as potential disease-modifying agents in Parkinson's and Alzheimer's disease: mechanisms, clinical trial evidence, and the neuroprotection horizon
Frontiers in aging neuroscience · 2026
PubMedClinical outcomes with initial oral triple and dual therapy in echocardiography-defined connective tissue disease-associated pulmonary hypertension: a retrospective single-center cohort study
Journal of thoracic disease · 2026 Oct 30
Longevity and metabolic signaling
PRN tracks this theme because it connects reader demand with published research, regulatory questions and clinical relevance.
GLP-1 receptor agonists as potential disease-modifying agents in Parkinson's and Alzheimer's disease: mechanisms, clinical trial evidence, and the neuroprotection horizon
Frontiers in aging neuroscience · 2026
PubMedCardiovascular-kidney-metabolic syndrome: novel molecular mechanism and glucagon-like peptide-1-targeting therapy
Frontiers in cell and developmental biology · 2026
PubMedSGLT-2 Inhibitors versus GLP-1 Receptor Agonists for Dementia and Depression in Type 2 Diabetes Mellitus: A Meta-Analysis
Diabetes, metabolic syndrome and obesity : targets and therapy · 2026
Recovery and tissue biology
PRN tracks this theme because it connects reader demand with published research, regulatory questions and clinical relevance.
Core-Shell Microneedles for Sequential Delivery of Antibacterial, Antioxidant, and Anti-Inflammatory Agents in Infected Wound Healing
Advanced healthcare materials · 2026 Nov 3
PubMedMechanical stimulation activates Postn-mediated Wnt/β-catenin pathway to enhance BMSCs paracrine function and promote wound healing in diabetic rats
Stem cell research & therapy · 2026 Jul 31
PubMedPossibilities for Cytoprotective Liver Therapy, Stable Gastric Pentadecapeptide BPC 157, and Standard Agents-A Narrative Review
Pharmaceuticals (Basel, Switzerland) · 2026 Oct 1